Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
MALARIA CONSORTIUM has floated a tender for Artemisinin-Based Combination Therapy (ACT) Pharmaceutical Market Expert. The project location is Nigeria and the tender is closing on 11 Aug 2018. The tender notice number is , while the TOT Ref Number is 25576061. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Nigeria
Summary : Artemisinin-Based Combination Therapy (ACT) Pharmaceutical Market Expert
Deadline : 11 Aug 2018
Other Information
Notice Type : Tender
TOT Ref.No.: 25576061
Document Ref. No. :
Competition : ICB
Financier : Other Funding Agencies
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : MALARIA CONSORTIUM
Nigeria
Nigeria
Email :hr.recruitment@malariaconsortium.org
Tender Details
Tenders are invited for Artemisinin-Based Combination Therapy (ACT) Pharmaceutical Market Expert Opportunity.
? Location: Nigeria
? Deadline for application: 11 August 2018
? Duration of consultancy: 15 working days between August and October 2018
Malaria Consortium is recruiting for a Consultant on ACT Pharmaceutical market development to work in Nigeria. In 2017, NMEP developed a Private Health Sector ACT Sustainability Plan for Nigeria however the GFATM is not looking to extend the ACT copayment mechanism beyond the last orders which were delivered in the first quarter of 2018.
The national transition plan will guide the process in introducing an alternative arrangement to the ACT co-payment mechanism. The Consultant will work with a small team of national experts (national private sector expert, national commercial/finance expert, national pharmacist, national market development expert) to provide technical assistance to the National Malaria Elimination Programme (NMEP) and work with in-country stakeholders to develop a transition plan for the ACT Private Sector Co-payment Mechanism (PSCSM).
The consultant will:
? liaise with key in-country stakeholders expected to contribute to the development process of the national transition plan
? lead the development, by working closely with NMEP and the project team, of a national transition plan which should include an implementation framework and results measurement.
? lead the design and writing of an ACT market share analysis for quality-assured ACTs (pre-qualified, NAFDAC approved)
? lead the design of an ACT value chain analysis for quality-assured ACTs (pre-qualified, NAFDAC approved) of which the findings should inform the development of the transition plan
? participate in a key stakeholder consultations to gather perspectives, and provide technical assistance to NMEP; the role of parasite-based diagnosis will be an addition to the implementation framework.
? review existing published and unpublished documents and extract data or information relevant to the national transition plan
The successful candidate will have:
? A post-graduate qualification in a pharmaceutical related field
? Substantial experience in anti-malarial commodities such as Artemisinin-based Combination Therapies is essential
? Substantial experience in anti-malaria commodities in Nigeria is desirable ? Familiarity with current global trends in malaria pharmaceuticals, and challenges and opportunities in increasing access to ACTs through the private sector
? Experience working with national and international pharma
? Excellent written and oral communications skills
Please send your CV and daily fee rate (in USD) with a covering letter to: hr.recruitment@malariaconsortium.org
Documents
Want To Bid in This Tender?
Get Local Agent Support in Nigeria and 60 More Countries.
View Tenders By
Sign in with Google